Multiple Sclerosis (MS)
Home / Multiple Sclerosis (MS)
Multiple Sclerosis (MS)
Multiple Sclerosis (MS) is a chronic demyelinating disease mediated by immune attacks on the central nervous system myelin. Therapeutic advances have led to over 20 disease-modifying therapies (DMTs), including:
- Anti-CD20 monoclonal antibodies (ocrelizumab, ofatumumab)
- S1P receptor modulators (fingolimod, ozanimod, ponesimod)
- Immune reconstitution therapies (alemtuzumab, cladribine)
The goal of MS treatment has evolved toward early, high-efficacy therapy to preventirreversible disability.
Your Financial Contribution Can Help Us Fund Critical Programs & Initiatives
As a Nonprofit organization, we are deeply committed to raising awareness, providing patient support, and advocating for research for individuals living with various disease states.
Quick Links
Rare Diseases
Contact Us
For general questions about our organization, our mission, or how you can get involved, please email us. We endeavor to respond to all inquiries